Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Sunil Shah | M | 51 |
Alevin Therapeutics Ltd.
 Alevin Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Alevin Therapeutics Ltd. is a British company that focuses on developing safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies. The company is based in Cambridge, UK and was founded in 2022 by Chris Moody, Thomas McInally, Alison John. The company's preclinical pipeline features small molecules that target integrin receptors. | - |
| Alice Laura MacGowan | M | 48 |
Alevin Therapeutics Ltd.
Alevin Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Alevin Therapeutics Ltd. is a British company that focuses on developing safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies. The company is based in Cambridge, UK and was founded in 2022 by Chris Moody, Thomas McInally, Alison John. The company's preclinical pipeline features small molecules that target integrin receptors. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Chris Moody | M | - |
Alevin Therapeutics Ltd.
Alevin Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Alevin Therapeutics Ltd. is a British company that focuses on developing safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies. The company is based in Cambridge, UK and was founded in 2022 by Chris Moody, Thomas McInally, Alison John. The company's preclinical pipeline features small molecules that target integrin receptors. | - |
| Alison John | F | - |
Alevin Therapeutics Ltd.
Alevin Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Alevin Therapeutics Ltd. is a British company that focuses on developing safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies. The company is based in Cambridge, UK and was founded in 2022 by Chris Moody, Thomas McInally, Alison John. The company's preclinical pipeline features small molecules that target integrin receptors. | - |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Reino Unido | 4 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Thomas McInally
- Red Personal
